OpenURL Connection Search

Select item for more details and to access through your institution.

CSF Proteomic Signatures are Associated With Cognitive Decline in the Alzheimer's Disease Continuum.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078760
By:
- Vromen, Ellen M.;
- van Harten, Argonde C.;
- Berven, Frode;
- Teunissen, Charlotte E.;
- van der Flier, Wiesje M.;
- Pijnenburg, Yolande A.L.;
- Visser, Pieter Jelle;
- Tijms, Betty M.
Publication type:
Article
Is A+T‐ Alzheimer's disease or not? A combined CSF and pathology study.
Published in:
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.052023
By:
- Vromen, Ellen M.;
- de Boer, Sterre C.M.;
- Teunissen, Charlotte E.;
- Rozemuller, Annemieke J.M.;
- Visser, Pieter Jelle;
- Bouwman, Femke H.;
- Tijms, Betty M.
Publication type:
Article
Grey matter network markers identify individuals with prodromal Alzheimer's disease who will show rapid clinical decline.
Published in:
Brain Communications, 2022, v. 4, n. 2, p. 1, doi. 10.1093/braincomms/fcac026
By:
- Pelkmans, Wiesje;
- Vromen, Ellen M.;
- Dicks, Ellen;
- Scheltens, Philip;
- Teunissen, Charlotte E.;
- Barkhof, Frederik;
- van der Flier, Wiesje M.;
- Tijms, Betty M.
Publication type:
Article
Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers.
Published in:
Acta Neuropathologica, 2022, v. 144, n. 5, p. 821, doi. 10.1007/s00401-022-02454-z
By:
- Jansen, Iris E.;
- van der Lee, Sven J.;
- Gomez-Fonseca, Duber;
- de Rojas, Itziar;
- Dalmasso, Maria Carolina;
- Grenier-Boley, Benjamin;
- Zettergren, Anna;
- Mishra, Aniket;
- Ali, Muhammad;
- Andrade, Victor;
- Bellenguez, Céline;
- Kleineidam, Luca;
- Küçükali, Fahri;
- Sung, Yun Ju;
- Tesí, Niccolo;
- Vromen, Ellen M.;
- Wightman, Douglas P.;
- Alcolea, Daniel;
- Alegret, Montserrat;
- Alvarez, Ignacio
Publication type:
Article

Found: 4

CSF Proteomic Signatures are Associated With Cognitive Decline in the Alzheimer's Disease Continuum.

Is A+T‐ Alzheimer's disease or not? A combined CSF and pathology study.

Grey matter network markers identify individuals with prodromal Alzheimer's disease who will show rapid clinical decline.

Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers.